Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Esophageal Squamous Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07799077
What this trial is testing

Paclitaxel Polymeric Micelles and Cisplatin Plus Sintilimab as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT07263919
What this trial is testing

Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Akeso 90
Not applicableLooking for participantsNCT05327517
What this trial is testing

Surgery or Chemoradiotherapy for Cervical Esophageal Cancer

Who this might be right for
Cervical Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 192
Testing effectiveness (Phase 2)Looking for participantsNCT07622797
What this trial is testing

Exploratory Clinical Study of Camrelizumab Combined With Concurrent Chemoradiotherapy as an Organ-preserving Strategy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Late-stage Resectable Esophageal Squamous Carcinoma
The First Affiliated Hospital of Henan University of Science and Technology 164
Testing effectiveness (Phase 2)Looking for participantsNCT07385001
What this trial is testing

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaIvonescimabNeoadjuvant
Tang-Du Hospital 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07780721
What this trial is testing

Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer

Who this might be right for
Esophageal Cancer
The Affiliated Hospital of Putian University 31
Early research (Phase 1)Ended earlyNCT00290719
What this trial is testing

Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
University of California, San Francisco 6
Testing effectiveness (Phase 2)Looking for participantsNCT07162506
What this trial is testing

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 120
Post-approval studies (Phase 4)Not Yet RecruitingNCT06388135
What this trial is testing

Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Yang Jianjun, PhD 80
Testing effectiveness (Phase 2)Looking for participantsNCT06509568
What this trial is testing

Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CRIS-2 Trial）

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital 92
Testing effectiveness (Phase 2)Looking for participantsNCT06908382
What this trial is testing

Neoadjuvant QL1706 Therapy for ESCC

Who this might be right for
Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Shandong Provincial Hospital 32
Not applicableActive Not RecruitingNCT05951127
What this trial is testing

Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaOligometastatic Disease
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 141
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07490002
What this trial is testing

Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC

Who this might be right for
Esophageal Squamous Carcinoma
Changhai Hospital 33
Large-scale testing (Phase 3)Looking for participantsNCT04973306
What this trial is testing

Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma Stage IIEsophageal Squamous Cell Carcinoma Stage III
Shanghai Zhongshan Hospital 176
Large-scale testing (Phase 3)Looking for participantsNCT04280822
What this trial is testing

Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma

Who this might be right for
Esophageal CancerSurgeryNeoadjuvant Treatment+1 more
Henan Cancer Hospital 400
Testing effectiveness (Phase 2)Study completedNCT00445861
What this trial is testing

Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 27
Not applicableStudy completedNCT03001596
What this trial is testing

Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma Stage cT3-4aN0-1M0
Shanghai Zhongshan Hospital 264
Large-scale testing (Phase 3)Looking for participantsNCT04138212
What this trial is testing

Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital 456
Testing effectiveness (Phase 2)Looking for participantsNCT06272214
What this trial is testing

Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy

Who this might be right for
Adjuvant Radiotherapy
Zhejiang Cancer Hospital 146
Testing effectiveness (Phase 2)Study completedNCT00072033
What this trial is testing

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 66
Next Page